Resmed Inc. buy Mizuho
Start price
13.04.23
/
50%
€203.30
Target price
13.04.24
-
Performance (%)
-13.63%
End price
14.04.24
€175.60
Summary
This prediction ended on 14.04.24 with a price of €175.60. The prediction for Resmed Inc. disappointed with a performance of -13.63%. Mizuho has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. A total of €1.73 was paid as dividends for this prediction. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Resmed Inc. | 10.707% | 10.707% | -22.183% | -7.580% |
| iShares Core DAX® | 1,01 % | 2,70 % | 4,36 % | 51,69 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % | 18,00 % | 67,99 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % | 40,91 % | 57,11 % |
| iShares S&P 500 | -2,72 % | -1,75 % | 16,97 % | 58,87 % |
Comments by Mizuho for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at Mizuho. They set a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten